agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
3.885
+0.065 (1.70%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Company Description
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States.
It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month.
The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc.
in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.
agilon health, inc.
| Country | United States |
| Founded | 2016 |
| IPO Date | Apr 15, 2021 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 1,076 |
| CEO | Steven Sell |
Contact Details
Address: 440 Polaris Parkway, Suite 550 Westerville, Ohio 43082 United States | |
| Phone | 562 256 3800 |
| Website | agilonhealth.com |
Stock Details
| Ticker Symbol | AGL |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $23.00 |
| CIK Code | 0001831097 |
| CUSIP Number | 00857U107 |
| ISIN Number | US00857U1079 |
| Employer ID | 37-1915147 |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| Steven Jackson Sell | President, Chief Executive Officer and Director |
| Girish Venkatachaliah | Chief Technology Officer |
| Benjamin Shaker | Chief Markets Officer |
| Timothy Gertsch | Vice President, Controller and Chief Accounting Officer |
| Leland Thomas | Senior Manager of Investor Relations |
| Denise Zamore | Chief Legal Officer and Secretary |
| Mat Varghese | Chief People Officer |
| Bill Farry | Chief of Technology Innovation |
| Kenny Bellendir | Markets Chief Financial Officer |
| Dr. Kevin P. Spencer M.D. | Chief Clinical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 17, 2025 | ARS | Filing |
| Apr 17, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 17, 2025 | DEF 14A | Other definitive proxy statements |
| Mar 7, 2025 | SCHEDULE 13G/A | Filing |
| Feb 25, 2025 | 10-K | Annual Report |
| Feb 25, 2025 | 8-K | Current Report |
| Feb 14, 2025 | SCHEDULE 13G | Filing |
| Dec 6, 2024 | SCHEDULE 13G/A | Filing |
| Dec 5, 2024 | 8-K | Current Report |
| Nov 19, 2024 | 8-K | Current Report |